Clinical Trial Update: A Study to Assess Multidomain Endpoints of an ECG Patch

View source ↗

Summary

AstraZeneca completed a clinical trial evaluating multidomain endpoints of an ECG patch in patients with Acute Decompensated Heart Failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decomposed Heart Failure

Snippet

Sponsor: AstraZeneca | Conditions: Acute Decompensated Heart Failure | Status: COMPLETED